PYCR1 Promotes Glutamine Metabolism and the Progression of Lung Adenocarcinoma by Regulating the Expression of OPLAH

Researchers identified the pyrroline-5-carboxylate reductase 1 (PYCR1)/OPLAH axis as a key driver of LUAD progression via p53 signaling, revealing a promising therapeutic target.